358 related articles for article (PubMed ID: 37495999)
1. Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study.
Kristensen FPB; Christensen DH; Mortensen MB; Maeng M; Kahlert J; Sørensen HT; Thomsen RW
Cardiovasc Diabetol; 2023 Jul; 22(1):187. PubMed ID: 37495999
[TBL] [Abstract][Full Text] [Related]
2. Lipid Levels and Risk of Diabetic Polyneuropathy in 2 Danish Type 2 Diabetes Cohorts.
Kristensen FPB; Christensen DH; Callaghan BC; Nielsen JS; Højlund K; Andersen H; Dekkers OM; Groenwold RHH; Sørensen HT; Thomsen RW
Neurology; 2024 Jul; 103(1):e209538. PubMed ID: 38833657
[TBL] [Abstract][Full Text] [Related]
3. Comparison of on-Statin Lipid and Lipoprotein Levels for the Prediction of First Cardiovascular Event in Type 2 Diabetes Mellitus.
Kim JY; Choi J; Kim SG; Kim NH
Diabetes Metab J; 2023 Nov; 47(6):837-845. PubMed ID: 37915183
[TBL] [Abstract][Full Text] [Related]
4. Contribution of remnant cholesterol to cardiovascular risk.
Langsted A; Madsen CM; Nordestgaard BG
J Intern Med; 2020 Jul; 288(1):116-127. PubMed ID: 32181933
[TBL] [Abstract][Full Text] [Related]
5. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.
Vallejo-Vaz AJ; Fayyad R; Boekholdt SM; Hovingh GK; Kastelein JJ; Melamed S; Barter P; Waters DD; Ray KK
Circulation; 2018 Aug; 138(8):770-781. PubMed ID: 29618599
[TBL] [Abstract][Full Text] [Related]
6. Statin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study.
Fung CSC; Wan EYF; Chan AKC; Lam CLK
BMC Cardiovasc Disord; 2017 Jun; 17(1):166. PubMed ID: 28645252
[TBL] [Abstract][Full Text] [Related]
7. Risk of major adverse cardiovascular events associated with elevated low-density lipoprotein cholesterol in a population with atherosclerotic cardiovascular disease with and without type 2 diabetes: a UK database analysis using the Clinical Practice Research Datalink.
Morgan CL; Durand A; McCormack T; Hughes E; Berni TR; Lahoz R
BMJ Open; 2023 Nov; 13(11):e064541. PubMed ID: 38030254
[TBL] [Abstract][Full Text] [Related]
8. Statin Discontinuation and Cardiovascular Events Among Older People in Denmark.
Thompson W; Morin L; Jarbøl DE; Andersen JH; Ernst MT; Nielsen JB; Haastrup P; Schmidt M; Pottegård A
JAMA Netw Open; 2021 Dec; 4(12):e2136802. PubMed ID: 34854906
[TBL] [Abstract][Full Text] [Related]
9. Evaluating different low-density lipoprotein cholesterol thresholds to initiate statin for prevention of cardiovascular diseases in patients with type 2 diabetes mellitus: A target trial emulation study.
Wan EYF; Xu W; Mok AHY; Chin WY; Yu EYT; Chui CSL; Chan EWY; Wong ICK; Lam CLK; Danaei G
Diabetes Obes Metab; 2024 May; 26(5):1877-1887. PubMed ID: 38379445
[TBL] [Abstract][Full Text] [Related]
10. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
[TBL] [Abstract][Full Text] [Related]
11. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
Castañer O; Pintó X; Subirana I; Amor AJ; Ros E; Hernáez Á; Martínez-González MÁ; Corella D; Salas-Salvadó J; Estruch R; Lapetra J; Gómez-Gracia E; Alonso-Gomez AM; Fiol M; Serra-Majem L; Corbella E; Benaiges D; Sorli JV; Ruiz-Canela M; Babió N; Sierra LT; Ortega E; Fitó M
J Am Coll Cardiol; 2020 Dec; 76(23):2712-2724. PubMed ID: 33272365
[TBL] [Abstract][Full Text] [Related]
12. Elevated triglyceride levels are associated with increased risk for major adverse cardiovascular events in statin-naïve rheumatoid arthritis patients: A nationwide cohort study.
Choi W; Kang JH; Park JY; Hong AR; Yoon JH; Kim HK; Kang HC
Semin Arthritis Rheum; 2023 Dec; 63():152274. PubMed ID: 37844386
[TBL] [Abstract][Full Text] [Related]
13. Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study.
Kim JY; Choi J; Kim SG; Kim NH
Cardiovasc Diabetol; 2022 Feb; 21(1):28. PubMed ID: 35193571
[TBL] [Abstract][Full Text] [Related]
14. Triglyceride and Triglyceride/ HDL (High Density Lipoprotein) Ratio Predict Major Adverse Cardiovascular Outcomes in Women With Non-Obstructive Coronary Artery Disease.
Prasad M; Sara J; Widmer RJ; Lennon R; Lerman LO; Lerman A
J Am Heart Assoc; 2019 May; 8(9):e009442. PubMed ID: 31014162
[TBL] [Abstract][Full Text] [Related]
15. Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis.
Pedersen SB; Langsted A; Nordestgaard BG
JAMA Intern Med; 2016 Dec; 176(12):1834-1842. PubMed ID: 27820614
[TBL] [Abstract][Full Text] [Related]
16. Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid.
Chapman MJ; Zamorano JL; Parhofer KG
Pharmacol Ther; 2022 Sep; 237():108172. PubMed ID: 35304222
[TBL] [Abstract][Full Text] [Related]
17. High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real-World Administrative Claims Analysis of Statin-Treated Patients With High Residual Cardiovascular Risk.
Toth PP; Granowitz C; Hull M; Liassou D; Anderson A; Philip S
J Am Heart Assoc; 2018 Aug; 7(15):e008740. PubMed ID: 30371242
[TBL] [Abstract][Full Text] [Related]
18. Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study.
Huh JH; Han KD; Cho YK; Roh E; Kang JG; Lee SJ; Ihm SH
Cardiovasc Diabetol; 2022 Nov; 21(1):228. PubMed ID: 36324177
[TBL] [Abstract][Full Text] [Related]
19. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
[TBL] [Abstract][Full Text] [Related]
20. Association of lipoprotein levels with mortality in subjects aged 50 + without previous diabetes or cardiovascular disease: a population-based register study.
Bathum L; Depont Christensen R; Engers Pedersen L; Lyngsie Pedersen P; Larsen J; Nexøe J
Scand J Prim Health Care; 2013 Sep; 31(3):172-80. PubMed ID: 23941088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
